Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance

Emerging infectious diseases(2024)10.3201/eid3008.240541Source: DataRank Database

Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance is a research paper published in Emerging infectious diseases (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (30)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Theresa Ryckman ORCID,Nicolas A. Menzies ORCID,Richard G. White ORCID,Ted Cohen ORCID,Emily A. Kendall ORCID

Live enrichment

PubMed:39043388 PMC:PMC11286077

NIAID NIH HHS

Grant: R01 AI147321

Wellcome Trust

Grant: 218261/Z/19/Z

UK Research and Innovation

Grant: ES/P008011/1

Infection prevention and control for drug-resistant tuberculosis in South Africa in the era of decentralised care: a whole systems approach

National Institutes of Health

Grant: 1R01AI147321-01

Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking well

Wellcome Trust

Grant: 218261

Improving scientific and public health decision making by developing technologies to increase use of robust methods to calibrate and analyse complex mathematical models

Wellcome Trust

goldLicense: cc-by

publisherhttps://wwwnc.cdc.gov/eid/article/30/8/pdfs/24-0541.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11286077/pdf/24-0541.pdf

repositoryhttps://researchonline.lshtm.ac.uk/id/eprint/4673543/1/McQuaid-etal-Potential-of-Pan-Tuberculosis-treatment.pdf

repositoryhttps://doaj.org/article/b02f90d3b22e4ed2a77920fd3855f766

Unpaywallhttps://doi.org/10.3201/eid3008.240541

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansMycobacterium tuberculosisTuberculosisTuberculosis, Multidrug-ResistantRifampinAntitubercular AgentsTreatment OutcomeMicrobial Sensitivity TestsDrug Resistance, Bacterial

Keywords

BacteriaAntimicrobial resistanceTbTuberculosis And Other MycobacteriaResearchRAntitubercular AgentsInfectious and parasitic diseasesRC109-216Mycobacterium tuberculosisMicrobial Sensitivity TestsTreatment OutcomeTuberculosis, Multidrug-ResistantDrug Resistance, BacterialMedicineHumansTuberculosisRifampin

Sustainable Development Goals

SDG 3: 3. Good health

Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance

FAIR Checklist

Authors (6)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)